Advertisement

Surgery pp 1429-1456 | Cite as

Venous Disease and Pulmonary Embolism

  • Gregory L. Moneta
  • Mathew I. Foley

Abstract

Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in the United States. Although precise figures are difficult to obtain as a consequence of undiagnosed cases, the annual incidence of VTE has been estimated at 71 and 117 per 100,000 by two different recent retrospective population-based studies (Worcester and Olmstead Counties).1,2 Their reported annual incidences for deep venous thrombosis were nearly identical (48 per 100,000), but for pulmonary embolus (PE) there was great disparity (23 versus 69 per 100,000). This difference was believed to be secondary to the threefold higher rate of autopsy acquisition in Olmstead County as compared to the U.S. average.2 In-hospital case-fatality rates were also different, 12% versus 28%, respectively. Based on the Worcester data, Anderson and Wheeler have estimated the prevalence of clinically significant VTE at 600,000 cases per year, with as many as two-thirds of these being undiagnosed.3 Deep venous thrombosis (DVT) poses not only the immediate threat of pulmonary embolus (PE) but chronic disability secondary to venous insufficiency as well. PE is estimated to be responsible for the deaths of 50,000 to 100,000 persons per year in U.S. hospitals who would not otherwise be expected to die of their underlying disease process.4, 5, 6 Despite this awareness and evidence for the efficacy of various forms of prophylaxis, attention toward prevention remains inadequate.7

Keywords

Inferior Vena Cava Deep Venous Thrombosis Varicose Vein Inferior Vena Cava Filter Venous Ulcer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep venous thrombosis and pulmonary embolus. Arch Intern Med 1991;151:933–938.PubMedCrossRefGoogle Scholar
  2. 2.
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism; a 25-year population-based study. Arch Intern Med 1998;158:585–593.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson FA Jr, Wheeler HB. Venous thromboembolism, risk factors and prophylaxis. Clin Chest Med 1995;16(2):235–251.PubMedGoogle Scholar
  4. 4.
    Dalen JE, Albert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:257–270.Google Scholar
  5. 5.
    Dismuke SE, Wagner EH. Pulmonary embolism as a cause of death; the changing mortality in hospitalized patients. JAMA 1986;255(15):2039–2042.PubMedCrossRefGoogle Scholar
  6. 6.
    Salzman EW, Hirsh J. The epidemiology, pathogenesis, and natural history of venous thromboembolism. In: Colman RW; Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Philadelphia: Lippincott, 1994:1275–1296.Google Scholar
  7. 7.
    Anderson FA Jr, Wheeler HB. Physician practices in the management of venous thromboembolism: a community wide survey. J Vasc Surg 1992;16:707–714.PubMedCrossRefGoogle Scholar
  8. 8.
    Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosner DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992;152:1660–1664.PubMedCrossRefGoogle Scholar
  9. 9.
    Carter CJ, Anderson FA Jr, Wheeler HB. Epidemiology and pathophysiology of venous thromboembolism. In: Hull RD, Raskob GE, Pineo GF, eds. Venous Thromboembolism: An Evidence-Based Atlas. Armonk: Futura, 1996:3–27.Google Scholar
  10. 10.
    Nicolaides AN, Irving D. Clinical factors and the risk of deep venous thrombosis. In: Nicolaides AN, eds. Thromboembolism: Aetiology, Advances in Prevention and Management. Lancaster: MTP Press, 1975:193–204.Google Scholar
  11. 11.
    Kakkar W, Howe CT, Nicolaides AN, Renney JTG, Clarke MB. Deep venous thrombosis of the leg. Is there a “high risk” group? Am J Surg 1970;120:527–530.PubMedCrossRefGoogle Scholar
  12. 12.
    Nordstrom M, Lindblad B, Bergquist D, Jellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155–160.PubMedGoogle Scholar
  13. 13.
    Samama MM, Simmoneau G, Wainstein JP, et al. SIRIUS study: epidemiology of risk factors of deep venous thrombosis of the lower limbs in community practice. Thromb Haemostasis 1993;69(6):763.Google Scholar
  14. 14.
    Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients; results of meta-analysis. Ann Surg 1988;208(2):227–240.PubMedCrossRefGoogle Scholar
  15. 15.
    Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement. J Bone Joint Surg 1984;66A(2):194–201.Google Scholar
  16. 16.
    Hull RD, Raskob GE. Current concepts review; prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg 1986;68A(1):146–150.Google Scholar
  17. 17.
    Olin JW, Graor RA, O’Hara P, Young JR. The incidence of deep venous thrombosis in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 1993;18:1037–1041.PubMedCrossRefGoogle Scholar
  18. 18.
    Gillinov AM, Davis EA, Alberg AJ, et al. Pulmonary embolism in the cardiac surgical patient. Ann Thorac Surg 1992;53:988–991.PubMedGoogle Scholar
  19. 19.
    Reis SE, Polak JF, Hirsch DR, et al. Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. Am Heart J 1991;122:478.PubMedCrossRefGoogle Scholar
  20. 20.
    Phlegmasia alba dolens. In: Trousseau A. Lectures on Clinical Medicine, Delivered at the Hotel-Dieu, Paris [Cormack JR, transl.]. London: New Syndenham Society, 1872:281–295.Google Scholar
  21. 21.
    Walsh JJ, Bonnar J, Wright FW. A study of pulmonary embolism and deep vein thrombosis after major gynaecological surgery using labeled fibrinogen-phlebography and lung scanning. J Obstet Gynaecol Br Commonw 1974;81:311–316.PubMedGoogle Scholar
  22. 22.
    Sue-Ling HM, Johnston D, McMahon MJ, et al. Preoperative identification of patients at high risk for deep venous thrombosis after elective major abdominal surgery. Lancet 1986;1:1173–1176.PubMedCrossRefGoogle Scholar
  23. 23.
    Goldberg RJ, Seneff M, Gore JM, et al. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med 1987;147:251–253.PubMedCrossRefGoogle Scholar
  24. 24.
    Prandoni P, Lensing AWA, Buller HR, et al. Deep-vein thrombosis and the incidence of subsequent cancer. N Engl J Med 1992;327:1128–1133.PubMedGoogle Scholar
  25. 25.
    Bloom JW, Doggen CJM, Osmoto S, et al. Malignancies, prothrombotic mutatios, and the risk of venous thrombosis. JAMA 2005;293:715–722.CrossRefGoogle Scholar
  26. 26.
    WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346:1575–1582.Google Scholar
  27. 27.
    Priten KJ, Miller EV, Mason E, et al. Venous thrombosis in the morbidly obese. Surg Gynecol Obstet 1978;147:63–64.Google Scholar
  28. 28.
    Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism: a clinico-pathological study in injured and burned patients. Br J Surg 1961;48:475–489.PubMedCrossRefGoogle Scholar
  29. 29.
    Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601–1606.PubMedCrossRefGoogle Scholar
  30. 30.
    Shackford SR, Davis JW, Hollingsworth-Fridlund P, et al. Venous thromboembolism in patients with major trauma. Am J Surg 1990;159:365–369.PubMedCrossRefGoogle Scholar
  31. 31.
    Winchell RJ, Hoyt DB, Walsh JC, et al. Risk factors associated with pulmonary embolism despite routine prophylaxis: implications for improved protection. J Trauma 1994;37(4):600–606.PubMedCrossRefGoogle Scholar
  32. 32.
    May R. Varicose veins. In: May R, ed. Surgery of the Veins of the Leg and Pelvis. Stuttgart: Theime, 1979.Google Scholar
  33. 33.
    Jorgensen JO, Hanel KC, Morgan AM, Hunt JM. The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs. J Vasc Surg 1993;18:70–73.PubMedCrossRefGoogle Scholar
  34. 34.
    Mauer BJ, Wray R, Shillingford JP. Frequency of venous thrombosis after myocardial infarction. Lancet 1971;ii:1385–1387.CrossRefGoogle Scholar
  35. 35.
    Kotilainen M, Ristola P, Ikkala E, Pyorala K. Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction. Ann Clin Res 1973;5:365–368.PubMedGoogle Scholar
  36. 36.
    Handley AJ, Emerson PA, Fleming PR. Heparin in the prevention of deep vein thrombosis after myocardial infarction. Br Med J 1972;2:436–438.PubMedCrossRefGoogle Scholar
  37. 37.
    Warlow C, Terry G, Kenmure ACF, et al. A double-blind trial of low-dose subcutaneous heparin in the prevention of deep vein thrombosis after myocardial infarction. Lancet 1973;2:934–937.PubMedCrossRefGoogle Scholar
  38. 38.
    Devor M, Barrett-Connor E, Renvall M, et al. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 1991;92:275–282.CrossRefGoogle Scholar
  39. 39.
    Boston Collaborative Drug Surveillance Program. Surgically confirmed gall bladder disease, venous thromboembolism, and breast tumours in relation to post-menopausal estrogen therapy. N Engl J Med 1974;290:15–19.Google Scholar
  40. 40.
    Cushman M, and the Woman’s Health Initiative Investigators. Estrogen plus progestin and the risk of venous thrombosis. JAMA 2004;292:1573–1580.PubMedCrossRefGoogle Scholar
  41. 41.
    Smith NL, Heckbert SR, Lemaitre RN, et al. Esterfied estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004;292;1581–1587.PubMedCrossRefGoogle Scholar
  42. 42.
    Gibbs NM. Venous thrombosis of the lower limbs with particular reference to bedrest. Br J Surg 1957;45:209–236.PubMedCrossRefGoogle Scholar
  43. 43.
    Waring WP, Karunas RS. Acute spinal cord injuries and the incidence of clinically occuring thromboembolic disease. Paraplegia 1991;29:8–16.PubMedGoogle Scholar
  44. 44.
    Green D, Lee Y, Ito VY, et al. Fixed-vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury. JAMA 1988;260:1255–1258.PubMedCrossRefGoogle Scholar
  45. 45.
    Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular weight heparin. Ann Intern Med 1990;113:571–574.PubMedGoogle Scholar
  46. 46.
    Ginsberg JS, Brill-Edwards P, Burrows RF, et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemostasis 1992;67(5):519–520.Google Scholar
  47. 47.
    Hull RD, Raskob GE, Carter CJ. Serial impedance plethysmography in pregnant patients with clinically suspected deep venous thrombosis. Ann Intern Med 1990;112:663–667.PubMedGoogle Scholar
  48. 48.
    Monreal M, Raventos A, Lerma R, et al. Pulmonary embolus in patients with upper extremity DVT associated to venous central lines: a prospective study. Thromb Haemostasis 1994;72(4):548–550.Google Scholar
  49. 49.
    Dollery CM, Sullivan ID, Bauraind O, et al. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet 1994;344:1043–1045.PubMedCrossRefGoogle Scholar
  50. 50.
    Trottier SJ, Veremakis C, O’Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective randomized trial. Crit Care Med 1995;23(1):52–59.PubMedCrossRefGoogle Scholar
  51. 51.
    Meredith JW, Young JS, O’Neil EA, et al. Femoral catheters and deep venous thrombosis: a prospective evaluation with venous duplex sonography. J Trauma 1993;35(2):187–191.PubMedCrossRefGoogle Scholar
  52. 52.
    Shefler A, Gillis J, Lam A, et al. Inferior vena cava thrombosis as a complication of femoral vein catheterisation. Arch Dis Child 1995;72:343–345.PubMedCrossRefGoogle Scholar
  53. 53.
    Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability, congenital and acquired causes of thrombosis. Med Clin N Am 1998;82(3):409–458.PubMedCrossRefGoogle Scholar
  54. 54.
    Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for thrombosis. N Engl J Med 1994;330:517–522.PubMedCrossRefGoogle Scholar
  55. 55.
    Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet I 960;1:1309–1312.Google Scholar
  56. 56.
    Markel A, Manzo RA, Bergelin RO, Strandness DE Jr. Pattern and distribution of thrombi in acute venous thrombosis. Arch Surg 1992;127:305–309.PubMedGoogle Scholar
  57. 57.
    Kakkar W, Howe CT, Franc C, Clarke MB. Natural history of postoperative deep venous thrombosis. Lancet 1969;2:230–232.PubMedCrossRefGoogle Scholar
  58. 58.
    Nicolaides AN, Kakkar W, Field ES, Renney JTG. The origin of deep venous thrombosis: a venographic study. Br J Radiol 1971;44:653–663.PubMedCrossRefGoogle Scholar
  59. 59.
    Philbrik JT, Becker DM. Calf deep venous thrombosis; a wolf in sheep’s clothing. Arch Intern Med 1988;148:2131–2138.CrossRefGoogle Scholar
  60. 60.
    Doouss TW. The clinical significance of venous thrombosis of the calf. Br J Surg 1976;63:377–378.PubMedCrossRefGoogle Scholar
  61. 61.
    Kakkar W, Lawrence D. Hemodynamic and clinical assessment after therapy for deep vein thrombosis: a prospective study. Am J Surg 1985;150(4A):54–63.PubMedGoogle Scholar
  62. 62.
    Langerstedt CI, Olsson CG, Fagher BO, et al. Need for longterm anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985;2:515–518.CrossRefGoogle Scholar
  63. 63.
    Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855–858.PubMedGoogle Scholar
  64. 64.
    Bentley PG, Kakkar W, Scully MF, et al. An objective study of alternative methods of heparin administration. Thromb Res 1980;18:177–187.PubMedCrossRefGoogle Scholar
  65. 65.
    Schulman S, Granqvist S, Juhlin-Danfelt A, et al. Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase. Acta Med Scand 1986;219:349–357.PubMedGoogle Scholar
  66. 66.
    Kistner RL, Ball JJ, Nordyke RA, et al. Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremities. Am J Surg 1972;124:169–176.PubMedCrossRefGoogle Scholar
  67. 67.
    Menzoian JO, Sequeira JC, Doyle JE, et al. Therapeutic and clinical course of deep vein thrombosis. Am J Surg 1983;146:581–585.PubMedCrossRefGoogle Scholar
  68. 68.
    Holmgren K, Andersson G, Fagrell B, et al. One-month versus six-month therapy with oral anticoagulants after symptomatic deep venous thrombosis. Acta Med Scand 1985;218:279–284.PubMedGoogle Scholar
  69. 69.
    Schulman S, Lockner D, Juhlin-Dannfelt A. The duration of oral anticoagulation after deep vein thrombosis: a randomized study. Acta Med Scand 1985;217:547–552.PubMedGoogle Scholar
  70. 70.
    Lohr JM, Kerr TM, Lutter KS, et al. Lower extremity calf thrombosis: to treat or not to treat. J Vasc Surg 1991;14:618–623.PubMedCrossRefGoogle Scholar
  71. 71.
    Passman MA, Moneta GL, Taylor LM, et al. Pulmonary embolism is associated with the combination of isolated calf vein thrombosis and respiratory symptoms. J Vasc Surg 1997;25:39–45.PubMedCrossRefGoogle Scholar
  72. 72.
    Hull RD, Raskob GE, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109–1114.PubMedGoogle Scholar
  73. 73.
    Brandjes DPM, Heijboer H, Buller HR, et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327:1485–1489.PubMedCrossRefGoogle Scholar
  74. 74.
    Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661–1665.PubMedCrossRefGoogle Scholar
  75. 75.
    Moser KM, Fedullo PF, Littejohn JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994;271:223–225.PubMedCrossRefGoogle Scholar
  76. 76.
    Nielsen HK, Husted SE, Kursell LR, et al. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med 1994;235:457–461.PubMedGoogle Scholar
  77. 77.
    Caprinin JA, Arcelus JI, Hoffman KN, et al. Venous duplex imaging follow-up of acute symptomatic deep vein thrombosis of the leg. J Vasc Surg 1995;21:472–476.CrossRefGoogle Scholar
  78. 78.
    Donaldson GA, Williams C, Scannel JG, et al. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism: report of a successful pulmonary-artery thrombectomy using cardiopulmonary bypass. N Engl J Med 1963;268:171–174.PubMedCrossRefGoogle Scholar
  79. 79.
    Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240–1245.PubMedGoogle Scholar
  80. 80.
    Dalen JE, Banas JS Jr, Brooks HL, et al. Resolution rate of acute pulmonary embolus in man. N Engl J Med 1992;280:1194–1199.CrossRefGoogle Scholar
  81. 81.
    National Heart, Lung and Blood Institute. Urokinase Pulmonary Embolism Trial: phase I results. JAMA 1970;214:2163–2172.CrossRefGoogle Scholar
  82. 82.
    Salzman EW, Hirsh J. Prevention of venous thromboembolism. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott, 1987:1253.Google Scholar
  83. 83.
    Clagett GP, Anderson FA Jr, Levine MN, et al. Prevention of venous thromboembolism. Chest 1992;4:391S–407S.CrossRefGoogle Scholar
  84. 84.
    Kakkar W, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993;341:259–265.PubMedCrossRefGoogle Scholar
  85. 85.
    Nurmohamed MT, Verhaeghe R, Haas S, et al. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995;169:567–571.PubMedCrossRefGoogle Scholar
  86. 86.
    Koppenhagen K, Adolf J, Matthes M, et al. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Thromb Haemostasis 1992;67(6):627–630.Google Scholar
  87. 87.
    Geerts WH, Pineo, GF, Heit JA, et al. Prevention of venous thromboembolism: the 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:388S–400S.CrossRefGoogle Scholar
  88. 88.
    Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM. Prophylactic agents for venous thrombosis in elective hip surgery; meta-analysis of studies using venographic assessment. Arch Intern Med 1993;153:2221–2228.PubMedCrossRefGoogle Scholar
  89. 89.
    Francis CW, Pellegrini VD, Marder VJ, et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 1992;267:2911–2915.PubMedCrossRefGoogle Scholar
  90. 90.
    Hull R, Delmore TJ, Hirsh J, et al. Effectiveness of intermittent pulsatile stockings for prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res 1979;16:37–45.PubMedCrossRefGoogle Scholar
  91. 91.
    McKenna R, Galante J, Bachman F, et al. Prevention of venous thromboembolism after total knee replacement using high-dose aspirin or intermittent calf and thigh compression. Br Med J 1980;1:514–517.CrossRefGoogle Scholar
  92. 92.
    Cerrato D, Ariano C, Fiacchino F. Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 1978;137:378–381.Google Scholar
  93. 93.
    Dennis JW, Menawat S, Von Thron J, et al. Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups. J Trauma 1993;35(1):132–139.PubMedCrossRefGoogle Scholar
  94. 94.
    Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;355:701–707.CrossRefGoogle Scholar
  95. 95.
    Rogers FB, Shackford SR, Ricci MA, et al. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg 1995;180(6):641–647.PubMedGoogle Scholar
  96. 96.
    Alexander JJ, Yuhas JP, Piotrowski JJ. Is the increasing use of prophylactic percutaneous IVC filters justified. Am J Surg 1994;168:102–106.PubMedCrossRefGoogle Scholar
  97. 97.
    Harris EJ Jr, Kinney EV, Harris EJ Sr, et al. Phlegmasia complicating prophylactic inferior vena caval interruption: a work of caution. J Vasc Surg 1995;22:606–611.PubMedCrossRefGoogle Scholar
  98. 98.
    Ray CE, Mitchell EL, Zipser S, et al. Outcomes with retrievable vena cava filters: a multicenter study. J Vasc Intervent Radiol 2006;17:1595–1604.CrossRefGoogle Scholar
  99. 99.
    Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge; an undetermined risk. Arch Surg 1992;127:310–313.PubMedGoogle Scholar
  100. 100.
    Trowbridge A, Boese CK, Woodruff B, et al. Incidence of post-hospital proximal deep venous thrombosis after total hip arthroplasty; a pilot study. Clin Orthop Res 1994;299:203–208.Google Scholar
  101. 101.
    Planes A, Vochelle N, Darmon J, et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996;348:224–228.PubMedCrossRefGoogle Scholar
  102. 102.
    Hull RD, Hirsh J, Sackett DL, et al. Clinical validity of a negative venogram in patients with a clinically suspected venous thrombosis. Circulation 1981;64:622–625.PubMedGoogle Scholar
  103. 103.
    Bettmann MA, Salzman EW, Rosenthal D, et al. Reduction of venous thrombosis complicating phlebography. Am J Roentgenol 1980;134:1169–1172.Google Scholar
  104. 104.
    Walters HL, Clemenson J, Browse NL, Lea TM. 125I-Fibrinogen uptake following phlebography of the leg: comparison of ionic and nonionic contrast media. Radiology 1980;135:619–621.PubMedGoogle Scholar
  105. 105.
    Laerum F, Holm HA. Post-phlebographic thrombosis. Radiology 1981;140:651–654.PubMedGoogle Scholar
  106. 106.
    AbuRahma AF, Powell M, Robinson PA. Prospective study of safety of lower extremity phlebography with nonionic contrast medium. Am J Surg 1996;171:255–257.PubMedCrossRefGoogle Scholar
  107. 107.
    Comerota AJ, Katz ML, Grossi RJ, et al. The comparative value of noninvasive testing for diagnosis and surveillance of deep vein thrombosis. J Vasc Surg 1988;7:40–49.PubMedCrossRefGoogle Scholar
  108. 108.
    Cruickshank MK, Levine MN, Hirsh J, et al. An evaluation of impedance plethysmography and 1251-fibrinogen leg scanning in patients following hip surgery. Thromb Haemostasis 1989;62(3):830–834.Google Scholar
  109. 109.
    Hull RD, Hirsh J, Carter CJ, et al. Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis; a randomized trial. Ann Intern Med 1985;102:21–28.PubMedGoogle Scholar
  110. 110.
    Huisman MV, Buller HR, ten Cate JW, Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients; the Amsterdam general practitioner study. N Engl J Med 1986;314:823–828.PubMedGoogle Scholar
  111. 111.
    Huisman MV, Buller HR, ten Cate JW, et al. Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting. Arch Intern Med 1989;149:511–513.PubMedCrossRefGoogle Scholar
  112. 112.
    Agnelli G, Cosmi B, Ranucci V, et al. Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery; a venography-controlled study. Ann Intern Med 1991;151:2167–2171.CrossRefGoogle Scholar
  113. 113.
    Paiement G, Wessinger SJ, Waltman AC, et al. Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients; impedance phlebography and fibrinogen scanning versus roentgenographic phlebography. Am J Surg 1988;155:400–404.PubMedCrossRefGoogle Scholar
  114. 114.
    Anderson DR, Lensing AWA, Wells PS, et al. Limitations of impedance plethysmography in the diagnosis of clinically suspected deep-vein thrombosis. Ann Intern Med 1993;118:25–30.PubMedGoogle Scholar
  115. 115.
    Lensing AWA, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320:342–345.PubMedGoogle Scholar
  116. 116.
    Cronan JJ, Dorfman GS, Scola FH, et al. Deep venous thrombosis: US assessment using vein compression. Radiology 1987;162:191–194.PubMedGoogle Scholar
  117. 117.
    Appelman PT, De Jong TE, Lampmann LE. Deep venous thrombosis of the leg: US findings. Radiology 1987;163:743–746.PubMedGoogle Scholar
  118. 118.
    Vogel P, Laing FC, Jeffrey RB Jr, Wing VW. Deep venous thrombosis of the lower extremity: US evaluation. Radiology 1987;163:747–751.PubMedGoogle Scholar
  119. 119.
    O’Leary DH, Kane RA, Chase BM. A prospective study of the efficacy of B-scan sonography in the detection of deep venous thrombosis in the lower extremities. J Clin Ultrasound 1988;16:1–8.PubMedCrossRefGoogle Scholar
  120. 120.
    Lensing AWA, Levi MM, Buller HR, et al. Diagnosis of deep vein thrombosis using an objective doppler method. Ann Intern Med 1990;113:9–13.PubMedGoogle Scholar
  121. 121.
    Heijboer H, Cogo A, Buller HR, et al. Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients. Arch Intern Med 1992;152:1901–1903.PubMedCrossRefGoogle Scholar
  122. 122.
    Heijboer H, Buller HR, Lensing AWA, et al. A randomized comparison of the clinical utility of real-time compression ultrasonography versus impedance plethysmography in the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 1993;329:1365–1369.PubMedCrossRefGoogle Scholar
  123. 123.
    Kearou C, Ginsberg JS, Donketis JS, et al. A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis; D-dimer testing compared with repeated ultrasonography. Ann Intern Med 2005;142:490–496.Google Scholar
  124. 124.
    Vermeer HJ, Ypma P, van Strijen MJL, et al. Exclusion of venous thromboembolism: evaluation of D-dimer PLUS for the quantitative determination of D-dimer. Thromb Res 2005;115:381–386.PubMedCrossRefGoogle Scholar
  125. 125.
    Constams J, Boutinet C, Salmi LR, et al. Comparison of four clinical prediction scores for the diagnosis of lower limb venous thrombosis in outpatients. Am J Med 2003;115:436–440.CrossRefGoogle Scholar
  126. 126.
    Wells PS, Brill-Edwards P, Stevens P, et al. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation 1995;91:2184–2187.PubMedGoogle Scholar
  127. 127.
    Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991;100:598–603.PubMedCrossRefGoogle Scholar
  128. 128.
    Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992;85:462–468.PubMedGoogle Scholar
  129. 129.
    Sasahara AA, Stein M, Simon M, Littmann D. Pulmonary angiography in the diagnosis of thromboembolic disease. N Engl J Med 1964;270:1075–1081.PubMedCrossRefGoogle Scholar
  130. 130.
    The Urokinase Pulmonary Embolism trial: a national cooperative study. Circulation 1973;47(suppl II):II-1–II-108.Google Scholar
  131. 131.
    Mills SR, Jackson DC, Older RA, et al. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series. Radiology 1980;136:295–299.PubMedGoogle Scholar
  132. 132.
    Dalen JE, Brooks HL, Johnson LW, et al. Pulmonary angiography in acute pulmonary embolism; indications, techniques, and results in 367 patients. Am Heart J 1971;81:175–185.PubMedCrossRefGoogle Scholar
  133. 133.
    Henry JW, Relyea B, Stein PD. Continuing risk of thromboem-boli among patients with normal pulmonary angiograms. Chest 1995;107:1375–1378.PubMedCrossRefGoogle Scholar
  134. 134.
    The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism; results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263:2753–2759.CrossRefGoogle Scholar
  135. 135.
    Stein PD, Coleman RE, Gottschalk A, et al. Diagnostic utility of ventilation/perfusion lung scans in acute pulmonary embolism is not diminished by pre-existing cardiac or pulmonary disease. Chest 1991;100:604–606.PubMedCrossRefGoogle Scholar
  136. 136.
    Bounameaux H, Cirafici P, DeMoerloose P, et al. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 1991;337:196–200.PubMedCrossRefGoogle Scholar
  137. 137.
    Turkstra F, van Beek EJR, ten Cate JW, Buller HR. Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients. Thromb Haemostasis 1996;76(1 ):9–11.Google Scholar
  138. 138.
    Killewich LA, Nunnelee JD, Auer Al. Value of lower extremity venous duplex examination in the diagnosis of pulmonary embolism. J Vasc Surg 1993;17:934–939.PubMedCrossRefGoogle Scholar
  139. 139.
    Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983;98:891–899.PubMedGoogle Scholar
  140. 140.
    Kruit WHJ, DeBoer AC, Sing AK, Van Roon F. The significance of venography in the management of patients with clinically suspected pulmonary embolism. J Intern Med 1991;230:333–339.PubMedGoogle Scholar
  141. 141.
    Schiebler ML, Holland GA, Hatabu H, et al. Suspected pulmonary embolism: prospective evaluation with pulmonary MR angiography. Radiology 1993;189:125–131.PubMedGoogle Scholar
  142. 142.
    Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006;354:2317–2327.PubMedCrossRefGoogle Scholar
  143. 143.
    Markel A, Manzo RA, Standness DE. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med 1992;152:1265–1267.PubMedCrossRefGoogle Scholar
  144. 144.
    Goldhaber SZ, Hirsch DR, MacDougall RC, et al. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. Am Heart J 1996;132:314–318.PubMedCrossRefGoogle Scholar
  145. 145.
    Tiller WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933;58:485.CrossRefGoogle Scholar
  146. 146.
    MacFarlane RG, Pilling J. Fibrinolytic activity of normal urine. Nature (Lond) 1947;159:779.CrossRefPubMedGoogle Scholar
  147. 147.
    Rijken DC, Wijngaards G, Zaal-Dejong M, et al. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 1979;580:140.PubMedGoogle Scholar
  148. 148.
    Goldhaber SZ, Buring JE, Lipnik RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984;76:393–397.PubMedCrossRefGoogle Scholar
  149. 149.
    Robertson BR, Nilsson IM, Nylander G. Value of streptokinase and heparin in treatment of acute deep venous thrombosis: a coded investigation. Acta Chir Scand 1968;134:203–208.PubMedGoogle Scholar
  150. 150.
    Porter JM, Seaman AJ, Common HH, et al. Comparison of heparin and streptokinase in the treatment of venous thrombosis. Am Surg 1975;41:511–519.PubMedGoogle Scholar
  151. 151.
    Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis; an interim report of a prospective trial. Br J Surg 1979;66:838–843.PubMedCrossRefGoogle Scholar
  152. 152.
    Kakkar W, Flanc C, Howe CT, et al. Treatment of deep vein thrombosis: a trial of heparin, streptokinase, and arvin. Br Med J 1969;1:806–810.PubMedCrossRefGoogle Scholar
  153. 153.
    Robertson BR, Nilsson IM, Nylander G. Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand 1970;136:173–180.PubMedGoogle Scholar
  154. 154.
    Tsapogas MJ, Peabody RA, Wu KT, et al. Controlled study of thrombolytic therapy in deep vein thrombosis. Surgery (St. Louis) 1973;74:973–984.PubMedGoogle Scholar
  155. 155.
    Goldhaber SZ, Polak JF, Feldstein ML, et al. Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis. Am J Cardiol 1994;73:75–79.PubMedCrossRefGoogle Scholar
  156. 156.
    Kakkar W, Lawrence D. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis; a prospective study. Am J Surg 1985:54–63.Google Scholar
  157. 157.
    Comerota AJ, Aldridge SC, Cohen G, et al. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg 1994;20:244–254.PubMedGoogle Scholar
  158. 158.
    Molina JE, Hunter D, Yedlicka JW. Thrombolytic therapy for iliofemoral venous thrombosis. Vasc Surg 1992;26:630–637.Google Scholar
  159. 159.
    National Heart and Lung Institute Cooperative Study Group: Urokinase-Streptokinase Embolism Trial: Phase II results. JAMA 1974;229:1606–1613.CrossRefGoogle Scholar
  160. 160.
    NIH Consensus Development Conference: thrombolytic therapy in treatment. Br Med J 1980;1:1585.Google Scholar
  161. 161.
    Goldhaber SZ, Vaughan DE, Markis JE, et al. Acute pulmonary embolus treated with tissue plasminogen activator. Lancet 1986;ii:886–889.CrossRefGoogle Scholar
  162. 162.
    Goldhaber SZ, Kessler CM, Heit J, et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988;ii:293–298.CrossRefGoogle Scholar
  163. 163.
    Dalla-Volta S, Palla A, Santolicandro A, et al. PAIMS 2: altepase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 1992;20:520–526.PubMedCrossRefGoogle Scholar
  164. 164.
    Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. J Am Coll Cardiol 1992;19:239–245.PubMedCrossRefGoogle Scholar
  165. 165.
    Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507–511.PubMedCrossRefGoogle Scholar
  166. 166.
    Verstraete M, Miller GAH, Bounameaus H, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353–360.PubMedGoogle Scholar
  167. 167.
    Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589–1595.PubMedCrossRefGoogle Scholar
  168. 168.
    Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram: a randomized controlled trial. Ann Intern Med 1993;119:874–881.PubMedGoogle Scholar
  169. 169.
    Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260–1264.PubMedCrossRefGoogle Scholar
  170. 170.
    Warkentin TE, Kelton JG. Heparin and platelets. Hematol Oncol Clin N Am 1990;4:243.Google Scholar
  171. 171.
    Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin of unfractionated heparin. N Engl J Med 1995;332:1330.PubMedCrossRefGoogle Scholar
  172. 172.
    Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemostasis 1992;68:95.Google Scholar
  173. 173.
    Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995;332:1374.PubMedCrossRefGoogle Scholar
  174. 174.
    Wallis DE, Lewis BE, Pifarre R, et al. Active surveillance for heparin-induced thrombocytopenia or thromboembolism. Chest 106;1994:106:120S.Google Scholar
  175. 175.
    Hirsch J, Raschke R, Warkentin TE, et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 1995;108(suppl):258–275.CrossRefGoogle Scholar
  176. 176.
    Link KP. The discovery of dicumarol and its sequels. Circulation 1959;19:97–107.PubMedGoogle Scholar
  177. 177.
    Link KP. The anticoagulant from spoiled sweet clover hay. Harvey Lect 1944;34:162–216.Google Scholar
  178. 178.
    Hirsh J, Dalen JE, Deykin D, et al. Oral anticogulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(suppl 4):231–465.CrossRefGoogle Scholar
  179. 179.
    Mohiuddin SM, Hilleman DE, Destache CJ, et al. Efficacy and safety of early versus late initiation of warfarin during therapy in acute thromboembolism. Am Heart J 1992;123:729–732.PubMedCrossRefGoogle Scholar
  180. 180.
    Safety and efficacy of warfarin started early after submassive venous thrombosis of pulmonary embolism. Lancet 1986;ii:1293–1296.Google Scholar
  181. 181.
    Coon WW, Willis PW III, Symons MJ. Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg 1969;170:559–568.PubMedCrossRefGoogle Scholar
  182. 182.
    Hull R, Delmore T, Genton E, et al. Warfarin versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855–858.PubMedCrossRefGoogle Scholar
  183. 183.
    Schulman S, Lockner D, Juhlin-Dannfelt A. The duration of anticoagulation after deep vein thrombosis: a randomized study. Acta Med Scand 1985;217:547–552.PubMedGoogle Scholar
  184. 184.
    Holmgren K, Andersson G, Fagrell B, et al. One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Med Scand 1985;218:279–284.PubMedGoogle Scholar
  185. 185.
    Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661–1665.PubMedCrossRefGoogle Scholar
  186. 186.
    Schulman S, Granqvist S, Holmstrom M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336:393–398.PubMedCrossRefGoogle Scholar
  187. 187.
    Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003;349:631–639.PubMedCrossRefGoogle Scholar
  188. 188.
    Eichinger S, Minar E, Bialouczyk KC, et al. D-Dimer levels and riskof recurrent venous thromboembolism. JAMA 2003;290:1071–1074.PubMedCrossRefGoogle Scholar
  189. 189.
    Palareti G, Cosmi B, Legnani C, et al. D-Dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006;355:1780–1789.PubMedCrossRefGoogle Scholar
  190. 190.
    Hron G, Kollars N, Binden BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006;296:397–402.PubMedCrossRefGoogle Scholar
  191. 191.
    Anderson LO, Barrowcliffe TW, Holmer E, et al. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X: effect of heparin neutralization in plasma. Thromb Res 1979;115:531–538.CrossRefGoogle Scholar
  192. 192.
    Fareed J, Walenga JM, Racanelli A, et al. Validity of the newly established low molecular weight heparin standard in cross referencing low molecular weight heparins. Haemostasis 1988;3(suppl):33–47.Google Scholar
  193. 193.
    Fareed J, Walenga JM, Hoppensteadt D, et al. Comparative study on the in vitro and in vivo activities of seven low-molecular weight heparins. Haemostasis 1988;18(suppl):3–15.PubMedGoogle Scholar
  194. 194.
    Boneu B, Caranobe C, Cadroy Y, et al. Pharmacokinetic studies of standard unfractionated heparin, and low molecular weight heparins in the rabbit. Semin Thromb Hemostasis 1988;14:18–27.CrossRefGoogle Scholar
  195. 195.
    Matzsch T, Bergqvist D, Hedner U, et al. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats. Thromb Haemostasis 1990;63:505–509.Google Scholar
  196. 196.
    Prandoni P, Lensing AW A, Buller HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992;339:441–445.PubMedCrossRefGoogle Scholar
  197. 197.
    Lindmarker P, Holstrom M, Granqvist S, et al. Comparison of once-daily subcutaneous fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemostasis 1994;72(2):186–190.Google Scholar
  198. 198.
    Simmonneau G, Charbonnier B, Decousus H, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 1993;153:1541–1546.CrossRefGoogle Scholar
  199. 199.
    Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975–982.PubMedGoogle Scholar
  200. 200.
    Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682–687.PubMedCrossRefGoogle Scholar
  201. 201.
    Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677–681.PubMedCrossRefGoogle Scholar
  202. 202.
    Hull RD, Raskob GE, Pineo GF, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329:1370–1376.PubMedCrossRefGoogle Scholar
  203. 203.
    Muir JM, Hirsh J, Weitz JI, et al. A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats. Blood 1997;89:3236–3242.PubMedGoogle Scholar
  204. 204.
    Murray WJ, Lindo VS, Kakkar W, et al. Long term administration of heparin and heparin fractions and osteoporosis in experimental animals. Blood Coagul Fibrinolysis 1995;6:113–118.PubMedCrossRefGoogle Scholar
  205. 205.
    Shaughnessy SG, Young E, Deschamps P, et al. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood 1995;86:1368–1373.PubMedGoogle Scholar
  206. 206.
    Kanter B, Moser KM. The Greenfield vena cava filter. Chest 1988;93:170–175.PubMedCrossRefGoogle Scholar
  207. 207.
    Molgaard CP, Yucel EK, Geller SC, et al. Access-site thrombosis after placement of inferior vena cava filters with 12-14 Fr delivery sheaths. Radiology 1992;185:257–261.PubMedGoogle Scholar
  208. 208.
    Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters; indications, safety, effectiveness. ArchlnternMed 1992;152:1985–1994.Google Scholar
  209. 209.
    Hammer FD, Rousseau HP, Joffre FG, et al. In vitro evaluation of vena cava filters. J Vasc Intervent Radiol 1994;5:869–876.CrossRefGoogle Scholar
  210. 210.
    Mohan CR, Hoballah JJ, Sharp WJ, et al. Comparative efficacy and complications of vena cava filters. J Vasc Surg 1995;21:235–246.PubMedCrossRefGoogle Scholar
  211. 211.
    Lohr JM, McDevitt DT, Lutter KS, et al. Operative management of greater saphenous thrombophlebitis involving the sapheno-femoral junction. Am J Surg 1992;164:269–275.PubMedCrossRefGoogle Scholar
  212. 212.
    Ascer E, Lorensen E, Pollina RM, et al. Preliminary results of a nonoperative approach to saphenofemoral junction thrombophlebitis. J Vasc Surg 1995;22:616–621.PubMedCrossRefGoogle Scholar
  213. 213.
    Lansing AM, Davis WM. Five-year follow-up study of iliofemoral venous thrombectomy. Ann Surg 1968;168:620–628.PubMedCrossRefGoogle Scholar
  214. 214.
    Juhan CM, Alimi YS, Barthelemy PJ, et al. Late results of iliofemoral venous thrombectomy. J Vasc Surg 1997;25:417–422.PubMedCrossRefGoogle Scholar
  215. 215.
    Lindner DJ, Edwards JM, Phinney ES, et al. Long-term hemodynamic and clinical sequelae of lower extremity deep venous thrombosis. J Vasc Surg 1986;4:436–442.PubMedCrossRefGoogle Scholar
  216. 206.
    Schmid C, Zietlow S, Wagner TOF, et al. Fulminant pulmonary embolism: symptoms, diagnostics, operative techniques and results. Ann Thorac Surg 1991;52:402–407.CrossRefGoogle Scholar
  217. 207.
    Kieny R, Charpentier A, Kieny MT. What is the place of pulmonary embolectomy today? J Cardiovasc Surg 1991;32:549–554.Google Scholar
  218. 208.
    Gulba DC, Schmid C, Borst H-B, et al. Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994;343:576–577.PubMedCrossRefGoogle Scholar
  219. 209.
    Greenfield LJ, Proctor MC, Williams DM, Wakefield TW. Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 1993;18:450–458.PubMedCrossRefGoogle Scholar
  220. 220.
    Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham study. Am J Prev Med 1988;4:96.PubMedGoogle Scholar
  221. 221.
    Madar G, Widmer LK, Zemp E, Maggs M. Varicose veins and chronic venous insufficiency—a disorder or disease? A critical epidemiological review. Vasa 1986;15:126.PubMedGoogle Scholar
  222. 222.
    Jamieson WG. State of the art of venous investigation and treatment. Can J Surg 1993;36:119.PubMedGoogle Scholar
  223. 223.
    Scott TE, La Morte WW, Gorin DR, et al. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 1995;22:622.PubMedCrossRefGoogle Scholar
  224. 224.
    Criado E, Johnson G Jr. Venous disease. Curr Probl 1991;28:339.CrossRefGoogle Scholar
  225. 225.
    Baker SR, Stacey MC, Jopp-McKay AG, et al. Ulcers. Br J Surg 1991;78:864.PubMedCrossRefGoogle Scholar
  226. 226.
    Cornwall JV, Dore CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. Br J Surg 1986;73:693.PubMedCrossRefGoogle Scholar
  227. 227.
    Lees TA, Lambert D. Prevalence of lower limb ulcers in an urban health district. Br J Surg 1992;79:1032.PubMedCrossRefGoogle Scholar
  228. 228.
    Phillips T, Stanton B, Provan A, et al. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994;31:49.PubMedCrossRefGoogle Scholar
  229. 229.
    Callam MJ, Harper DR, Dale JJ, Ruckley CV. Chronic leg ulceration: socioeconomic aspects. Scott Med J 1988;33:358.PubMedGoogle Scholar
  230. 230.
    Browse NL, Burnand KG, Thomas ML. Diseases of the Veins. Pathology, Diagnosis and Treatment. London: Hodder and Stoughton, 1988.Google Scholar
  231. 231.
    Callam MJ, Harper DR, Dale JJ, Ruckley CV. Chronic ulcer of the leg: clinical history. Br Med J 1987;294:1389.CrossRefGoogle Scholar
  232. 232.
    Abenhaim L, Kurx X, VEINES Study Collaborators. The VEINES Study: an international cohort study on chronic venous disorders of the leg. Angiology 1997;48:59.PubMedCrossRefGoogle Scholar
  233. 233.
    Clarke H, Smith SR, Vasdekis SN, et al. Role of venous elasticity in the development of varicose veins. Br J Surg 1989;76:577.PubMedCrossRefGoogle Scholar
  234. 234.
    Clarke GH. Venous elasticity. Doctoral thesis. London: University of London, 1989.Google Scholar
  235. 235.
    Clarke GH, Vasdekis SN, Hobbs JT, Nicolaides AN. Venous wall function in the pathogenesis of varicose veins. Surgery (St. Louis) 1992;111:402.PubMedGoogle Scholar
  236. 236.
    Nicolaides AN, Zukowski AJ. The value of dynamic pressure measurements. World J Surg 1986;10:919.PubMedCrossRefGoogle Scholar
  237. 237.
    Raju S, Fredericks R. Valve reconstruction procedures for nonobstructive venous insufficiency: rationale, techniques, and results in 107 procedures with two-to eight-year followup. J Vasc Surg 1988;7:301.PubMedCrossRefGoogle Scholar
  238. 238.
    Randhawa GK, Dhillon JS, Kistner RL, Ferries EB. Assessment of chronic venous insufficiency using dynamic venous pressure studies. Am J Surg 1984;148:203.PubMedCrossRefGoogle Scholar
  239. 239.
    Araki CT, Back TL, Padberg FT, et al. The significance of calf muscle pump function in venous ulceration. J Vasc Surg 1994;20:872.PubMedGoogle Scholar
  240. 240.
    Back TL, Padberg FT, Araki CT, et al. Limited range of motion is a significant factor in venous ulceration. J Vasc Surg 1995;22:519.PubMedCrossRefGoogle Scholar
  241. 241.
    van Bemmelen PS, Bedford G, Beach K, Strandness DE. Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg 1989;10:425.PubMedCrossRefGoogle Scholar
  242. 242.
    Rosfors S, Lamke LO, Nordstrom E, Bygdeman S. Severity and location of venous valvular insufficiency: the importance of distal valve function. Acta Chir Scand 1990;156:689.PubMedGoogle Scholar
  243. 243.
    Hanrahan LM, Araki CT, Rodriguez AA, et al. Distribution of valvular incompetence in patients with venous stasis ulceration. J Vasc Surg 1991;13:805.PubMedCrossRefGoogle Scholar
  244. 244.
    Moore DJ, Himmel PD, Summer DS. Distribution of venous valvular incompetence in patients with the postphlebitic syndrome. J Vasc Surg 1986;3:49.PubMedCrossRefGoogle Scholar
  245. 245.
    Sethia KK, Darke SG. Long saphenous incompetence as a cause of venous ulceration. Br J Surg 1984;71:754.PubMedCrossRefGoogle Scholar
  246. 246.
    Hoare MC, Nicolaides AN, Miles CR, et al. The role of primary varicose veins in venous ulceration. Surgery (St. Louis) 1982;92:450.PubMedGoogle Scholar
  247. 247.
    Labropoulos N, Giannoukas AD, Nicolaides AN, et al. New insights into the pathophysiologic condition of venous ulceration with color-flow duplex imaging: implications for treatment? J Vasc Surg 1995;22:45.PubMedCrossRefGoogle Scholar
  248. 248.
    Linton RR, Hardy IB. Postthrombotic syndrome of the lower extremity: treatment by interruption of the superficial femoral vein and ligation and stripping of the long and short saphenous veins. Surgery (St. Louis) 1948;24:452–468.PubMedGoogle Scholar
  249. 249.
    Strandness DE, Langlois Y, Cramer M, et al: Long-term sequelae of acute venous thrombosis. JAMA 1983;250:1289.PubMedCrossRefGoogle Scholar
  250. 250.
    Killewich LA, Bedford GR, Beach KW, Strandness DE. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989;9:89.PubMedCrossRefGoogle Scholar
  251. 251.
    Caps MT, Manzo RA, Bergelin RO, et al. Venous valvular reflux in veins not involved at the time of acute deep venous thrombosis. J Vasc Surg 1995;22:524.PubMedCrossRefGoogle Scholar
  252. 252.
    van Bemmelen PS. Venous Valvular Incompetence: An Experimental Study in the Rat. Alblasserdam: Offsetdrukkerij Kaners BV, 1984.Google Scholar
  253. 253.
    Leu HJ. Morphology of chronic venous insufficiency: light and electron microscopic examinations. Vasa 1991;20:330.PubMedGoogle Scholar
  254. 254.
    Wenner A, Leu HJ, Spycher M, et al. Ultrastructural changes of capillaries in chronic venous insufficiency. Exp Cell Biol 1980;48:1.CrossRefGoogle Scholar
  255. 255.
    Coleridge Smith PD. The role of white cell trapping in the pathogenesis of venous ulceration. Phlebol Dig 1992;4:4.Google Scholar
  256. 256.
    Veraart JCJM, Verhaegh MEJM, Neumann HAM, et al. Adhesion molecule expression in venous leg ulcers. Vasa 1993;2:243.Google Scholar
  257. 257.
    Pappas PJ, Teehan EP, Fallek SR, et al. Diminished mononuclear cell function is associated with chronic venous insufficiency. J Vasc Surg 1995;22:580.PubMedCrossRefGoogle Scholar
  258. 258.
    Hasan A, Murata H, Falabella A, et al. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-β. J Dermatol Sci 1997;16:59.PubMedCrossRefGoogle Scholar
  259. 259.
    Bollinger A, Leu AJ. Evidence for microvascular thrombosis obtained by intravital fluorescence videomicroscopy. Vasa 1991;20:252.PubMedGoogle Scholar
  260. 260.
    Leu AJ, Leu H-J, Franzeck UK, et al. Microvascular changes in chronic venous insufficiency: a review. Cardiovasc Surg 1995;3:237.PubMedCrossRefGoogle Scholar
  261. 261.
    Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982;285:1071.CrossRefGoogle Scholar
  262. 262.
    Wolf JH, Morland M, Browse NL. The fibrinolytic activity of varicose veins. Br J Surg 1979;66:185.CrossRefGoogle Scholar
  263. 263.
    Lotti T, Chimenti M, Bianchini G, et al. Cutaneous and plasmatic fibrinolytic activity in the subject of stasis dermatitis. Ital Gen Rev Dermatol 1983;20:9.Google Scholar
  264. 264.
    Vanscheidt W, Laaf H. Wokalck H, et al. Pericapillary fibrin cuff: a histologic sign of venous ulceration. J Cutan Pathol 1990;17:266.PubMedCrossRefGoogle Scholar
  265. 265.
    Taheri SA, Pollack L, Loomis R. P-13-NMR studies of muscle in patients with venous insufficiency. Int Angiol 1987;6:95.PubMedGoogle Scholar
  266. 266.
    Clyne CA, Ramsden WH, Chant AD, Webster JH. Oxygen tension on the skin of the gaiter area of limbs with venous disease. Br J Surg 1985;72:644.PubMedCrossRefGoogle Scholar
  267. 267.
    Mani R, White JE, Barrett DF, Weaver PW. Tissue oxygenation, venous ulcers and fibrin cuffs. J R Soc Med 1989;82:345.PubMedGoogle Scholar
  268. 268.
    Franzeck UK, Bollinger A, Huch R, Huch A. Transcutaneous oxygen tension and capillary morphology characteristics and density in patients with chronic venous incompetence. Circulation 1984;70:806.PubMedGoogle Scholar
  269. 269.
    Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp 1987;5:311.PubMedGoogle Scholar
  270. 270.
    Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J 1988;290:1693.CrossRefGoogle Scholar
  271. 271.
    Cikrit DF, Nichols WK, Silver D. Surgical management of refractory venous stasis ulceration. J Vasc Surg 1988;7:473.PubMedCrossRefGoogle Scholar
  272. 272.
    Bergan JJ, Yao JST, Flinn WR, McCarthy WJ. Surgical treatment of venous obstruction and insufficiency. J Vasc Surg 1986;3:174.PubMedCrossRefGoogle Scholar
  273. 273.
    Stewart AJ, Leaper DJ. Treatment of chronic leg ulcers in the community: a comparative trial of Scherisorb and Iodosorb. Phlebology 1987;2:115.Google Scholar
  274. 274.
    Ormiston MC, Seymour MT, Venn GE, et al. Controlled trial of Iodosorb in chronic venous ulcers. Br Med J 1985;291:308.CrossRefGoogle Scholar
  275. 275.
    Ryan TJ, Biven HF, Murphy JJ, et al. The use of a new occlusive dressing in the management of venous stasis ulceration. In: Ryan TJ, ed. An Environment for Healing: The Role of Occlusion. London: Royal Society of Medicine, 1984:99–103.Google Scholar
  276. 276.
    Eriksson G. Comparative study of hydrocolloid dressing and double layer bandage in treatment of venous stasis ulceration. In: Ryan TJ, ed. An Environment for Healing: The Role of Occlusion. London: Royal Society of Medicine, 1984:111–113.Google Scholar
  277. 277.
    Wright AD. The treatment of indolent ulcer of the leg. Lancet 1931;1:457.CrossRefGoogle Scholar
  278. 278.
    Aiming ST. Leg ulcers—the results of treatment. Angiology 1956;7:505.CrossRefGoogle Scholar
  279. 279.
    Kitahama A, Elliot LF, Kerstein MD, Menendez CV. Leg ulcer: conservative management or surgical treatment? JAMA 1982;247:197.PubMedCrossRefGoogle Scholar
  280. 280.
    Mayberry JC, Moneta GL, Taylor LM, Porter JM. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers. Surgery (St. Louis) 1991;109:575.PubMedGoogle Scholar
  281. 281.
    Chant AD, Davies LJ, Pike JM, Sparks MJ. Support stockings in practical management of varicose veins. Phlebology 1989;4:167.Google Scholar
  282. 282.
    Franks PJ, Oldroyd MI, Dickson D, et al. Risk factors for leg ulcer recurrence: a randomized trial of two types of compression stockings. Age Aging 1994;24:490–494.CrossRefGoogle Scholar
  283. 283.
    Unna PG. Ueber Paraplaste, eine neue Form medikamentoser Pflaster. Wien Med Wochenschr 1896;43:1854.Google Scholar
  284. 284.
    Rubin JR, Alexander J, Plecha EJ, Marman C. Unna’s boots vs. polyurethane foam dressings for the treatment of venous ulceration. Arch Surg 1990;125:489.PubMedGoogle Scholar
  285. 285.
    Kitka MJ, Schuler JJ, Meyer JP, et al. A prospective, randomized trial of Unna’s boots versus hydroactive dressing in the treatment of venous stasis ulcers. J Vasc Surg 1988;7:478.CrossRefGoogle Scholar
  286. 286.
    Cordts PR, Hanrahan LM, Rodriguez AA, et al. A prospective, randomized trial of Unna’s boot versus DuoDERM CGF hydroactive dressing plus compression in the management of venous leg ulcers. J Vasc Surg 1992;15:480.PubMedCrossRefGoogle Scholar
  287. 287.
    Vernick SH, Shapiro D, Shaw FD. Legging orthosis for venous and lymphatic insufficiency. Arch Phys Med Rehabil 1987;68:459.PubMedGoogle Scholar
  288. 288.
    Spence RK, Cahall E. Inelastic versus elastic leg compression in chronic venous insufficiency: a comparison of limb size and venous hemodynamics. J Vasc Surg 1996;24:783–787.PubMedCrossRefGoogle Scholar
  289. 289.
    Pekanmaki K, Kolari PJ, Kiistala U. Intermittent pneumatic compression treatment for postthrombotic leg ulcers. Clin Exp Dermatol 1987;12:350.PubMedCrossRefGoogle Scholar
  290. 290.
    Coleridge Smith P, Sarin S, Hasty J, Scurr JH. Sequential gradient pneumatic compression enhances venous ulcer healing: a randomized trial. Surgery (St. Louis) 1990;108:871.Google Scholar
  291. 291.
    Uber A. The socioeconomic profile of patients treated by phlebotropic drugs in Germany. Angiology 1997;48:595–607.PubMedCrossRefGoogle Scholar
  292. 292.
    Graves MW, Boyde TR. Plasma zinc concentrations in patients with psoriasis, other dermatoses, and venous leg ulceration. Lancet 1967;2:1019.CrossRefGoogle Scholar
  293. 293.
    Withers AF, Baker H, Musa M, Dormandy TL. Plasma zinc in psoriasis. Lancet 1968;2:278.PubMedCrossRefGoogle Scholar
  294. 293.
    Hallbook T, Lanner E. Serum-zinc and healing of venous leg ulcers. Lancet 1972;2:780.PubMedCrossRefGoogle Scholar
  295. 295.
    Myers MB, Cherry G. Zinc and the healing of chronic ulcers. Am J Surg 1970;120:77.PubMedCrossRefGoogle Scholar
  296. 296.
    Phillips A, Davidson M, Greaves MW. Venous leg ulceration: evaluation of zinc treatment, serum zinc and rate of healing. Clin Exp Dermatol 1977;2:395.PubMedCrossRefGoogle Scholar
  297. 297.
    Burnand K, Lemenson G, Morland M, et al. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression. Br Med J 1980;280:7.PubMedCrossRefGoogle Scholar
  298. 298.
    McMullin GM, Watkin GT, Coleridge Smith PD, Scurr JH. The efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency. Aust N Z J Surg 1991;61:306.PubMedCrossRefGoogle Scholar
  299. 299.
    Layer GT, Stacey MC, Burnand KG. Stanozolol and the treatment of venous ulceration: an interim report. Phlebology 1986;1:197.Google Scholar
  300. 300.
    Colgan M, Dormandy JA, Jones PW, et al. Oxpentifylline treatment of venous ulcers of the leg. Br Med J 1990;300:972–975.CrossRefGoogle Scholar
  301. 301.
    Balmer A, Limoni C. A double-blind placebo-controlled trial of venorutin on the symptoms and signs of chronic venous insufficiency. Vasa 1980;9:76.PubMedGoogle Scholar
  302. 302.
    Pulvertaft TB. Paroven in the treatment of chronic venous insufficiency. Practitioner 1979;223:838.PubMedGoogle Scholar
  303. 303.
    Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxyrutins. Results of a 660 patient multicenter study in the UK. Vasa 1983;12:373.PubMedGoogle Scholar
  304. 304.
    Mann RJ. A double-blind trial of oral O. B-hydroxy-ethyl rutosides for stasis leg ulcers. Br J Clin Pract 1981;35:79.PubMedGoogle Scholar
  305. 305.
    Casley-Smith JR, Casley-Smith JR. The effects of calcium dobesilate on acute lymphoedema (with and without macrophages) and on burn edema. Lymphology 1985;18:37.PubMedGoogle Scholar
  306. 306.
    Casley-Smith JR. The effect of variations in tissue protein concentration and tissue hydrostatic pressure on fluid and protein uptake by the initial lymphatics, and the action of calcium dobesilate. Microcirc Endothelium Lymphatics 1985;2:385.PubMedGoogle Scholar
  307. 307.
    Casley-Smith JR. A double-blind trial of calcium dobesilate in chronic venous insufficiency. Angiology 1988;39:853–857.PubMedCrossRefGoogle Scholar
  308. 308.
    Sullivan GW, Carper HT, Novick WJ, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immunol 1988;56:1722.Google Scholar
  309. 309.
    Layton AM, Ibbotson SH, Davies JA, et al. The effect of oral aspirin in the treatment of chronic venous leg ulcers. Lancet 1994;344:164–165.PubMedCrossRefGoogle Scholar
  310. 310.
    Ibbotsen SH, Layton AM, Davies JA, et al. The effect of aspirin on haemostatic activity in the treatment of chronic venous leg ulceration. Br J Dermatol 1995;132:422–426.CrossRefGoogle Scholar
  311. 311.
    Sinzinger H, Virgolini I, Fitscha P. Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1): an update. Vasa 1989;28 (suppl):6.Google Scholar
  312. 312.
    Rudofsky G. Intravenous prostaglandin Ex in the treatment of venous ulcers: a double-blind, placebo controlled trial. Vasa 1989;28 (suppl):39.Google Scholar
  313. 313.
    Diehm C, Trampisch HJ, Lange S, et al. Comparison of leg compression stockings and oral chest-horsenut seed extract in patients with chronic venous insufficiency. Lancet 1996;347:292–294.PubMedCrossRefGoogle Scholar
  314. 314.
    Gilchrist B, Reed C. The bacteriology of chronic venous ulcers treated with occlusive hydrocolloid dressings. Br J Dermatol 1989;121:337.PubMedCrossRefGoogle Scholar
  315. 315.
    Lineaweaver W, Howard R, Souey D, et al. Topical antimicrobial toxicity. Arch Surg 1985;120:267.PubMedGoogle Scholar
  316. 316.
    Roelens P. Double-blind placebo-controlled study with topical 2% ketanserin ointment in the treatment of venous ulcers. Dermatologica 1989;178:98.PubMedGoogle Scholar
  317. 317.
    Alvarez OM, Mertz PM, Eaglstein WH. The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds. J Surg Res 1983;35:142.PubMedCrossRefGoogle Scholar
  318. 318.
    Wilkins LM, Watson SR, Prosky SJ, et al. Development of a bilayered living skin construct for clinical applications. Biotechnol Bioeng 1994;43:747–756.PubMedCrossRefGoogle Scholar
  319. 319.
    Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol 1998;134(3):293–300.PubMedCrossRefGoogle Scholar
  320. 320.
    Linton RR. The communicating veins of the lower leg and the operative technique for their ligation. Ann Surg 1938;107:582–593.PubMedCrossRefGoogle Scholar
  321. 321.
    Gay J. Lettsonian Lectures 1867. Varicose Disease of the Lower Extremities. London: Churchill, 1868.Google Scholar
  322. 322.
    Homans f. The operative treatment of varicose veins and ulcers, based upon a classification of these lesions. Surg Gynecol Obstet 1916;22:143–158.Google Scholar
  323. 323.
    Linton RR. The post-thrombotic ulceration of the lower extremity: its etiology and surgical treatment. Ann Surg 1953;138:415–432.PubMedCrossRefGoogle Scholar
  324. 324.
    Gloviczki P, Bergan JJ, Menawat SS, et al. Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry. J Vasc Surg 1997;25:94–105.PubMedCrossRefGoogle Scholar
  325. 325.
    Sottiurai VS. Surgical correction of recurrent venous ulcer. J Cardiovasc Surg 1991;32:104–109.Google Scholar
  326. 326.
    Kistner RL. Surgical repair of venous valve. Straub Clin Proc 1968;34:41–43.Google Scholar
  327. 327.
    Kistner RL. Surgical repair of the incompetent femoral vein valve. Arch Surg 1975;110:1336–1342.PubMedGoogle Scholar
  328. 328.
    Masuda EM, Kistner RL. Long-term results of venous valve reconstruction: a four-to twenty-one-year follow-up. J Vasc Surg 1994;19:391–403.PubMedGoogle Scholar
  329. 329.
    Taheri SA, Pendergast DR, Lazar E, et al. Vein valve transplantation. Am J Surg 1985;150:201–202.PubMedCrossRefGoogle Scholar
  330. 330.
    Kistner RL. Methods for reconstruction of deep venous reflux: long-term results. Vasc Surg 1997;31(3):268–269.Google Scholar
  331. 331.
    Quinones-Baldrich WT. Thrombolytic therapy for vascular disease. In: Moore WS, ed. Vascular Surgery: A Comprehensive Review. Philadelphia: Saunders, 1998:361–389.Google Scholar
  332. 332.
    Christopoulos DG, Nicolaides AN, Szendro G, et al. Air-plethysmography and the effect of elastic compression on venous hemodynamics of the leg. J Vasc Surg 1987;5:148. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: Saunders, 1995:1838.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Gregory L. Moneta
    • 1
  • Mathew I. Foley
    • 2
  1. 1.Department of Vascular SurgeryOregon Health and Science UniversityPortlandUSA
  2. 2.Legacy Columbia Vascular and Endovascular DivisionLegacy Emanuel Hospital and Health CenterPortlandUSA

Personalised recommendations